期刊文献+

cDNA微阵列和组织微阵列对卵巢上皮性肿瘤基因的表达

Gene Expression Profiles to Epithelial Ovarian Tumors by Using cDNA Microarray and Tissue Microarrays
在线阅读 下载PDF
导出
摘要 【目的】结合cDNA微阵列和RNA与冰冻组织微阵列原位杂交的方法以寻找新的特异性卵巢癌候选癌基因,为卵巢癌的早期诊断和治疗提供理论依据。【方法】利用cDNA微阵列筛选在所有3种上皮性卵巢肿瘤中(卵巢浆液性交界性肿瘤、卵巢浆液性腺癌和卵巢子宫内膜样腺癌)显示有意义表达的基因,由RNA与冰冻组织微阵列原位杂交证实其结果。【结果】28个基因在>70%卵巢肿瘤中显示出高表达,18个基因在>70%卵巢肿瘤中低表达;干扰素诱导的转膜蛋白1(IITP1)被进一步用于RNA与冰冻组织微阵列原位杂交研究,其结果与cDNA微阵列研究结果相符合。【结论】将cDNA微阵列和RNA与冰冻组织微阵列原位杂交相结合是寻找卵巢癌候选癌基因的可行方法,研究中显示有意义表达的基因有可能作为新的上皮性卵巢癌候选癌基因。 Combining cDNA microarray with RNA i n situ hybridization on frozen tissue microarray to identify novel candidate oncogenes and provide possible theoretical basis for early diagnosis and treatment of ovarian c ancer.cDNA microarrays were used to seek significantly expressed genes in 3t ypes of ovarian tumors(serous borderline ovarian tumors,s erous ovarian cancers,and endometrioid ovarian carcinoma s).RNA in situ hybridization on frozen tissue microarray was used to confirm the fi nding from cDNA microarrays.In the study of cDNA microarray,28genes were over-expr essed and 18genes were under-expressed in >70%ovarian tumors.Interferon induced transme mbrane protein 1(IITP1)was further validated by RNA in situ hybridization on frozen tissue microarray.[Conclusion]The methods through combining cDNA microarray with RNA in situ hybridiz ation on frozen tissue microarray,i s an ideal choice for identifying novel oncogenes.The ge nes identified in this study might be the new candidate oncogenes of ovarian cancer.
作者 郑敏 Moch H
出处 《中山大学学报(医学科学版)》 CAS CSCD 北大核心 2004年第5期399-403,共5页 Journal of Sun Yat-Sen University:Medical Sciences
基金 瑞士国家自然科学基金资助项目(NationalScientificFundofSwitzerlandNo.E430573)
关键词 组织微阵列 CDNA微阵列 原位杂交 表达 卵巢癌 癌基因 RNA 膜蛋白 性腺 冰冻 epithelial ovarian tumors cDNA mic roarray tissue microarray oncogene
  • 相关文献

参考文献12

  • 1Iwamoto H, Fukasawa H, Honda T, et al. HER-2/neu expression in ovarian clear cell carcinomas[J]. Int J Gynecol Cancer, 2003, 13(1) :28-31.
  • 2Memarzadeh S, Lee S B, Berek J S, et al. CA125 levels are a weak predictor of optimal cytoreductive surgery in patients with advanced epithelial ovarian cancer[J]. Int J Gynecol Cancer, 2003, 13(2) :120-4.
  • 3Okuda T, Otsuka J, Sekizawa A, et al. p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer[J] . Gynecol Oncol,2003, 88(3) :318-25.
  • 4Moch H, Schraml P, Bubendorf L, et al. Highthroughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma[J]. Am J Pathol, 1999,154 (4): 981-6.
  • 5Struckmann K, Schraml P, Simon R, et al. Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinoma[J] . Cancer Res, 2004,64(5) :1632-8.
  • 6Deblandre G A, Marinx O P, Evans S S, et al. Expression cloning of an interferon-inducible 17-kDa membrane protein implicated in the control of cell growth[J].J Bio Chem, 1995, 270(40) :23860-6.
  • 7Mihara H, Kurihara T, Watanabe T, et al. cDNA cloning, purification, and characterization of mouse liver selenocysteine lyase. Candidate for selenium delivery protein in selenoprotein synthesis[J].J Bio Chem, 2000,275 (9): 6195 -200.
  • 8Umhauer S, Ruch R[J], Fanning J. Gap Junctional intercellular communication and connexin 43 expression in ovarian carcinoma[J] . Am J Obstet Gynecol, 2000, 182(5) :999-1000.
  • 9Venclovas C, Thelen M P. Structure-based predictions of Rad1, Rad9, Hus1 and Rad17 participation in sliding clamp and clamp-loading complexes[J] . Nucleic Acids Res, 2001, 28(13):2481-93.
  • 10Crosier M, Scott D, Wilson R G, et al. High expression of the trefoil protein TFF1 in interval breast cancers[J] . Am J Pathol, 2001, 159(1): 215-21.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部